Trial intelligence / Profile preview

Acetazolamide and Spironolactone in Acute Decompensated Heart Failure (DIURESIS-CHF)

NCT01973335Phase 4Completed

Sponsor
Hasselt University
Start
Nov 2013
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetazolamide, spironolactone in acute decompensated heart failure (ADHF), sponsored by Hasselt University. Started Nov 2013; status: completed.

02

Drugs

acetazolamidespironolactone
03

Conditions

acute decompensated heart failure (ADHF)

Beyond the preview

Go deeper on NCT01973335.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01973335.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call